Overview
Thymogen is a synthetic Glu-Trp dipeptide derived from thymic peptide research, used as a non-specific immunomodulator.
- Manufactured in Russia as a pharmaceutical
- Intramuscular injection
- Intranasal solution
Mechanism of action
Stimulates T-cell maturation and balances cellular and humoral immunity, restoring blunted responses after injury, infection, or chemotherapy.
- · T-cell maturation
- · Cytokine balance
- · Phagocytic activation
How it acts on the body
Thymogen is one of the shortest active fragments derived from thymic peptide research. It is used clinically in Russia as an adjunct in chronic infections, post-surgical immune suppression, and chemotherapy recovery, with the goal of normalizing T-cell counts and function.
Compared with Thymalin (a larger thymic extract), Thymogen is a defined dipeptide, easier to synthesize and standardize, and its effects are oriented toward T-cell maturation specifically.
Hormonal & endocrine impact
How this peptide is reported to shift specific hormones and signaling molecules. Directionality reflects research literature and preclinical models, not clinical prescribing data.
Curves are schematic shapes (sigmoid for increases/decreases, damped oscillation for modulation/stabilization) anchored to a 100% baseline. They communicate direction and tempo of change reported in research literature — not absolute hormone concentrations.
Effects on the body
Organ system effects
Primary site of action.
Thymic axis.
Reported effects
Drawn from preclinical research, anecdote, and small-scale clinical observation. No evidence grades are assigned — most peptides on this page lack rigorous human trials.
- Defined sequence, easy to standardize
- Well-tolerated
Potential side effects
- · Local injection-site reactions
- · Mild allergic responses
- · None well-documented
Drug interactions
Pairing context
- Nutritional support in catabolic statesImmune restoration requires substrate.
- Active autoimmune disease flareMay amplify autoreactive immunity.